Original Research
Published on 12 Sep 2023
Early clinical indicators of acute kidney injury caused by administering high-dose methotrexate therapy to juvenile pigs
in Onconephrology
Frontiers in Nephrology
doi 10.3389/fneph.2023.1193494
- 581 views
- Frontiers in Nephrology
- Onconephrology
- Articles
Type at least 3 characters
9 articles
Articles
Editorial
Published on 01 Aug 2023
Editorial: Women in onconephrology: 2022
in Onconephrology
Frontiers in Nephrology
doi 10.3389/fneph.2023.1240195
- 458 views
Case Report
Published on 20 Jul 2023
Case Report: Immune checkpoint inhibitor–induced multiorgan vasculitis successfully treated with rituximab
in Onconephrology
Frontiers in Nephrology
doi 10.3389/fneph.2023.1168614
- 1,405 views
Original Research
Published on 27 Feb 2023
The need for kidney biopsy in the management of side effects of target and immunotherapy
in Onconephrology
Frontiers in Nephrology
doi 10.3389/fneph.2023.1043874
- 1,481 views
Correction
Published on 05 Jan 2023
Corrigendum: Cemiplimab for advanced cutaneous squamous cell carcinoma in kidney transplant recipients
in Onconephrology
Frontiers in Nephrology
doi 10.3389/fneph.2022.1129134
- 313 views
Original Research
Published on 31 Oct 2022
Cemiplimab for advanced cutaneous squamous cell carcinoma in kidney transplant recipients
in Onconephrology
Frontiers in Nephrology
doi 10.3389/fneph.2022.1041819
- 2,008 views
- 1 citation
Review
Published on 19 Oct 2022
Immune checkpoint inhibitor related nephrotoxicity: Advances in clinicopathologic features, noninvasive approaches, and therapeutic strategy and rechallenge
in Onconephrology
Frontiers in Nephrology
doi 10.3389/fneph.2022.1017921
- 2,589 views
- 2 citations
Case Report
Published on 24 Mar 2022
Case Report: Roxadustat in Combination With Rituximab Was Used to Treat EPO-Induced Pure Red Cell Aplasia
in Onconephrology
Frontiers in Nephrology
doi 10.3389/fneph.2022.847847
- 1,282 views
Original Research
Published on 22 Mar 2022
Levels of Soluble NKG2D Ligands and Cancer History in Patients Starting Hemodialysis
in Onconephrology
Frontiers in Nephrology
doi 10.3389/fneph.2022.875207
- 1,157 views